![Menassie Taddese](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 153 042 $ as of 30/06/2026
Mr. Menassie Taddese is an Independent Director at Medexus Pharmaceuticals, Inc. He is on the Board of Directors at Medexus Pharmaceuticals, Inc. Mr. Taddese was previously employed as a President-Emerging Markets by Viatris, Inc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 25/09/2025 | 42,869 ( 0.14% ) | 153 042 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Director/Board Member | 06/02/2023 |
| Companies | Position | End |
|---|---|---|
| VIATRIS INC. | Corporate Officer/Principal | 01/12/2022 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
Medexus Pharmaceuticals, Inc.
 Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
